{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":14,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":14,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"b440a9f20b63","filters":{"venue":"Generics and Biosimilars Initiative Journal"}},"results":[{"id":"W2320750953","doi":"10.5639/gabij.2014.0303.033","title":"Subsequent entry biologics (biosimilars) in Canada: approaches to interchangeability and the extrapolation of indications and uses","year":2014,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Interchangeability; Extrapolation; Business; Medicine; Computer science; Mathematics; Internal medicine","authors":[{"name":"Ágnes Klein","is_ca":true},{"name":"Jian Wang","is_ca":true},{"name":"Patrick Bedford","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1409382763221571,"gpt":0.2574729309045367,"spread":0.1165346545823797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001523981,0.0001715595,0.0003705562,0.0001239437,0.0001947044,0.00002898754,0.0001338933,0.0001526257,0.00002101652],"category_scores_gemma":[0.0004557069,0.0001029237,0.00004109869,0.0002104317,0.0006803353,0.00005556799,0.0001529764,0.0003637082,1.592309e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007367395,"about_ca_system_score_gemma":0.0001492556,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006258361,"about_ca_topic_score_gemma":0.02526486,"domain_scores_codex":[0.9982221,0.000777609,0.000449193,0.0002453616,0.00005967144,0.0002460892],"domain_scores_gemma":[0.9989026,0.0005982154,0.000228049,0.0001280324,0.00007298473,0.00007018448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001726551,0.0004242773,0.7534044,0.0002362489,0.001009542,0.0000113714,0.007081868,0.00003055982,0.03870236,0.009543218,0.02751872,0.1603109],"study_design_scores_gemma":[0.005085505,0.0009357042,0.9060801,0.0002124942,0.0003347347,0.0003383326,0.004973345,0.001064049,0.03930106,0.02083356,0.02009907,0.0007420559],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8827823,0.0119685,0.00794601,0.09509326,0.0004978802,0.0007064041,0.0002455387,0.00001093047,0.0007492256],"genre_scores_gemma":[0.983778,0.002496481,0.002322173,0.01134552,0.00003124525,0.00001029137,0.000006721511,0.000006218883,0.000003378123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1595688,"threshold_uncertainty_score":0.9925215,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4229584754","doi":"10.5639/gabij.2014.0401.012","title":"Comparison of biosimilars guidelines","year":2014,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Medicine; Internal medicine","authors":[{"name":"GaBI Journal Editor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1402436365381827,"gpt":0.4017053913739141,"spread":0.2614617548357314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001316108,0.000278042,0.0006797032,0.0002008853,0.000317235,0.00004389016,0.0002743876,0.0003379122,0.0003336965],"category_scores_gemma":[0.0006534684,0.0001994767,0.0001901915,0.0002787102,0.0005473164,0.0000923758,0.0001437545,0.0005127843,0.000007740598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002058054,"about_ca_system_score_gemma":0.00005926341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":2.875715e-7,"about_ca_topic_score_gemma":0.000002626654,"domain_scores_codex":[0.9977928,0.0004568914,0.0009378687,0.0002907073,0.0001134817,0.0004082331],"domain_scores_gemma":[0.9983089,0.0002916646,0.0005445898,0.000204559,0.0005554791,0.00009483897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001230097,0.0002445807,0.02584405,0.00003855157,0.0003720014,0.000004019304,0.0002740265,0.0000120397,0.1758639,0.0002555212,0.7533907,0.04357762],"study_design_scores_gemma":[0.001788474,0.001431363,0.01146044,0.000152114,0.0002934946,0.0002667684,0.0007741733,0.0007328085,0.3837039,0.003494662,0.5953315,0.0005702496],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2513455,0.1098188,0.1842566,0.4029574,0.01516441,0.001538343,0.0008915845,0.0003578446,0.03366948],"genre_scores_gemma":[0.82636,0.004900535,0.05584993,0.1121118,0.0005335109,0.000007608195,0.00002949478,0.00006079686,0.0001462855],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5750145,"threshold_uncertainty_score":0.8134423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326320320","doi":"10.5639/gabij.2015.0401.009","title":"Health Canada’s perspective on the clinical development of biosimilars and related scientific and regulatory challenges","year":2015,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Perspective (graphical); Regulatory science; Business; Medicine; Computer science; Internal medicine; Pathology","authors":[{"name":"Ally Pen","is_ca":true},{"name":"Ágnes Klein","is_ca":true},{"name":"Jian Wang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1566998178822719,"gpt":0.3526119372573578,"spread":0.1959121193750858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003841761,0.0002251521,0.0004744995,0.0001205761,0.0006811041,0.00005021179,0.0001520184,0.0002146977,0.00002230054],"category_scores_gemma":[0.000441336,0.0001370557,0.00005545229,0.0001632987,0.001300766,0.00005562075,0.0001615077,0.0006141852,6.336227e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001462101,"about_ca_system_score_gemma":0.001627015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003707498,"about_ca_topic_score_gemma":0.004020132,"domain_scores_codex":[0.9975895,0.0008438134,0.000675603,0.0003932073,0.000155108,0.0003427968],"domain_scores_gemma":[0.9984403,0.0003775905,0.0004390191,0.000173024,0.0003715943,0.000198495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006465577,0.0006012478,0.008279542,0.00009651573,0.002141082,0.00005477857,0.01402804,0.000002152022,0.004216735,0.007394871,0.8541213,0.1084172],"study_design_scores_gemma":[0.007781723,0.004963475,0.3357602,0.0008513947,0.0004097214,0.001835141,0.0662488,0.0001075108,0.03054469,0.02376398,0.5260041,0.00172919],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3654431,0.1441589,0.0001114705,0.4831046,0.003090831,0.0005922237,0.0001446586,0.00002719866,0.003326996],"genre_scores_gemma":[0.9533316,0.01263697,0.003711745,0.03009352,0.00008731461,0.000005166627,0.000007694051,0.00002815295,0.000097845],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5878885,"threshold_uncertainty_score":0.5588967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119789362","doi":"10.5639/gabij.2021.1002.008","title":"Variation in the prices of oncology medicines across Europe and the implications for the future","year":2021,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadiana.org","funders":"","keywords":"Reimbursement; Population; Medicine; Per capita; Gross domestic product; Erlotinib; Life expectancy; Health care; Economics; Cancer; Internal medicine; Economic growth; Environmental health","authors":[{"name":"Brian Godman","is_ca":false},{"name":"Steven Simoens","is_ca":false},{"name":"Amanj Kurdi","is_ca":false},{"name":"Gisbert Selke","is_ca":false},{"name":"John Yfantopoulos","is_ca":false},{"name":"Andrew Hill","is_ca":false},{"name":"Jolanta Gulbinovič","is_ca":false},{"name":"Antony P. Martin","is_ca":false},{"name":"Angela Timoney","is_ca":false},{"name":"Dzintars Gotham","is_ca":false},{"name":"Janet Wale","is_ca":false},{"name":"Tomasz Bochenek","is_ca":false},{"name":"Iva Selke Krulichová","is_ca":false},{"name":"Eleonora Allocati","is_ca":false},{"name":"Iris Hoxha","is_ca":false},{"name":"Admir Malaj","is_ca":false},{"name":"A. Nachtnebel","is_ca":false},{"name":"Wouter Hamelinck","is_ca":false},{"name":"Zornitza Mitkova","is_ca":false},{"name":"Guenka Petrova","is_ca":false},{"name":"Ott Laius","is_ca":false},{"name":"Catherine Sermet","is_ca":false},{"name":"Irene Langner","is_ca":false},{"name":"Roberta Joppi","is_ca":false},{"name":"Elita Poplavska","is_ca":false},{"name":"Ieva Greičiūtė-Kuprijanov","is_ca":false},{"name":"Patricia Vella Bonanno","is_ca":false},{"name":"JF Hans Piepenbrink","is_ca":false},{"name":"Vincent de Valk","is_ca":false},{"name":"Robert Plisko","is_ca":false},{"name":"Magdałene Władysiuk","is_ca":false},{"name":"Vanda Marković‐Peković","is_ca":false},{"name":"Ileana Mardare","is_ca":false},{"name":"Tanja Novaković","is_ca":false},{"name":"Mark Parker","is_ca":false},{"name":"Jurij Fürst","is_ca":false},{"name":"D Tomek","is_ca":false},{"name":"Katarína Baňasová","is_ca":false},{"name":"Mercè Obach Cortadellas","is_ca":false},{"name":"Corrine Zara","is_ca":false},{"name":"Caridad Pontes","is_ca":false},{"name":"Maria Juhasz-Haverinen","is_ca":false},{"name":"Peter Skiöld","is_ca":false},{"name":"Stuart McTaggart","is_ca":false},{"name":"Durhane Wong‐Rieger","is_ca":false},{"name":"Stephen Campbell","is_ca":true},{"name":"Ruaraidh Hill","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05162742510960357,"gpt":0.3045067771538137,"spread":0.2528793520442102,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001549292,0.00007557993,0.0002272174,0.00003156738,0.0003334435,0.00008833109,0.0001611082,0.0000571489,0.000009249998],"category_scores_gemma":[0.0002845168,0.00003972775,0.00004984978,0.0001936891,0.0002215304,0.0001144476,0.00004350842,0.0001673591,3.32204e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000230791,"about_ca_system_score_gemma":0.00007100893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002021047,"about_ca_topic_score_gemma":0.00009178259,"domain_scores_codex":[0.9992751,0.0000442919,0.000401351,0.0001204965,0.0000202454,0.0001385524],"domain_scores_gemma":[0.9987414,0.0004998333,0.0004811168,0.0001151199,0.0001385299,0.00002401737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.0005449369,0.000354194,0.1058179,0.0001094889,0.0006805038,0.00001139478,0.068896,0.0002404385,0.000412463,0.5928348,0.124828,0.1052699],"study_design_scores_gemma":[0.001435953,0.000112005,0.6044384,0.000008868872,0.000024297,0.00007039752,0.002618683,0.0004055443,0.00001805289,0.06053741,0.3302495,0.00008084278],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.09096204,0.07774257,0.02181333,0.8025068,0.001179004,0.0005539256,0.0005506737,0.000003844456,0.004687816],"genre_scores_gemma":[0.8202922,0.1059027,0.001090573,0.07139515,0.001230735,0.00005258856,0.00000654465,0.000013619,0.0000158488],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7311116,"threshold_uncertainty_score":0.2564611,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2493092156","doi":"10.5639/gabij.2016.0502.014","title":"Adjusted indirect comparisons between generics – bioequivalence and interchangeability","year":2016,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Interchangeability; Bioequivalence; Medicine; Pharmacology; Computer science; Pharmacokinetics","authors":[{"name":"László Endrényi","is_ca":true},{"name":"László Tóthfalusi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2569267108682741,"gpt":0.3146563185770117,"spread":0.05772960770873753,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009203195,0.0002396744,0.0005415865,0.0002557648,0.0002596376,0.00014596,0.0002173213,0.0001439224,0.0001794914],"category_scores_gemma":[0.0001853031,0.0001921394,0.0000989534,0.0001993414,0.0003567282,0.0002893117,0.0002226653,0.0002809972,0.00002905065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001233774,"about_ca_system_score_gemma":0.00003946615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001067001,"about_ca_topic_score_gemma":0.00000870591,"domain_scores_codex":[0.9983223,0.00006773606,0.0007121292,0.0004086917,0.00004724344,0.0004418655],"domain_scores_gemma":[0.9986908,0.0002118037,0.0004685329,0.0001731283,0.00006756347,0.0003881319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005456524,0.0001194029,0.8289026,0.0000551865,0.0003496852,0.00001639149,0.0007878738,0.000002245309,0.001009087,0.002099467,0.1376592,0.02894426],"study_design_scores_gemma":[0.002590884,0.0005750643,0.4629802,0.0001053423,0.00008443431,0.0001452027,0.000209132,0.001238389,0.003427789,0.05543888,0.4720457,0.001158912],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8195518,0.01089167,0.02311688,0.1364241,0.001060099,0.000359755,0.002884216,0.00005700562,0.005654467],"genre_scores_gemma":[0.953549,0.01665454,0.002004747,0.02721715,0.0005137185,0.000008596402,0.000006288768,0.0000288803,0.00001705078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3659224,"threshold_uncertainty_score":0.7835217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2488281113","doi":"10.5639/gabij.2016.0502.016","title":"Biosimilars patent litigation in Canada and Japan: a comparative strategic overview and EU and US update","year":2016,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Amgen Canada","keywords":"Biosimilar; Business; International trade; Law and economics; Economics; Medicine; Internal medicine","authors":[{"name":"Brian J Malkin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1216381562871027,"gpt":0.2871633744820115,"spread":0.1655252181949087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005512736,0.0003119419,0.0005262751,0.0001386053,0.0002606341,0.00008344513,0.00009030852,0.0001991499,0.00009512781],"category_scores_gemma":[0.00004503132,0.0001956007,0.00003778179,0.0001824057,0.0005189302,0.0001686207,0.0001425014,0.0003692473,8.645315e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001133571,"about_ca_system_score_gemma":0.0002739219,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008760661,"about_ca_topic_score_gemma":0.04635924,"domain_scores_codex":[0.9981245,0.0004484861,0.0004953631,0.0004091609,0.00008577194,0.0004366947],"domain_scores_gemma":[0.999118,0.0002467302,0.0002494528,0.0001032802,0.0001240425,0.0001585434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001201039,0.0004273982,0.5381275,0.0003842976,0.001846432,0.0003965144,0.002369817,0.000004139838,0.2941873,0.002968312,0.0658994,0.09218787],"study_design_scores_gemma":[0.009450749,0.001707969,0.8718889,0.001127956,0.0004510572,0.002450103,0.004599051,0.0004035135,0.04522825,0.01368828,0.04716567,0.001838509],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9499243,0.02613323,0.00009540003,0.0228677,0.0002834744,0.0002089581,0.000275118,0.000008373385,0.0002033931],"genre_scores_gemma":[0.9290686,0.04626919,0.0007644335,0.02381896,0.00003993197,0.00000665613,0.000008141542,0.00001282244,0.00001131088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3337614,"threshold_uncertainty_score":0.9710422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2547846819","doi":"10.5639/gabij.2016.0503.032","title":"Are the perspectives regarding the use of biosimilars in the setting of haematology and blood and marrow transplant changing?","year":2016,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Hematology; Medicine; Internal medicine; Intensive care medicine","authors":[{"name":"Cherie Severson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06043340861617394,"gpt":0.2741436092015638,"spread":0.2137102005853899,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001630143,0.0001962329,0.0004145023,0.0001558406,0.0003865729,0.00004004134,0.000212263,0.0001839263,0.00001630777],"category_scores_gemma":[0.000368821,0.00007382371,0.0000916412,0.0002695718,0.001279955,0.00009827322,0.0001090963,0.0003917039,9.47918e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008511905,"about_ca_system_score_gemma":0.00002537707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.646553e-7,"about_ca_topic_score_gemma":0.00002502526,"domain_scores_codex":[0.9979889,0.000959235,0.0004218788,0.0002241963,0.00007823803,0.0003275897],"domain_scores_gemma":[0.9976731,0.001510569,0.0004938637,0.0001665632,0.0001293575,0.00002657997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008776733,0.0005046506,0.4913075,0.0002423213,0.00235147,0.0002785777,0.04799882,0.000003744227,0.4156927,0.002336043,0.02242956,0.0159769],"study_design_scores_gemma":[0.01046517,0.00235633,0.4932581,0.002816594,0.002826872,0.02361586,0.1554976,0.0002255087,0.2743042,0.007530812,0.02556584,0.001537114],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8861585,0.01473536,0.0006482017,0.09782127,0.0001602259,0.0002537235,0.0001723479,0.000005180607,0.00004521408],"genre_scores_gemma":[0.9810227,0.0103908,0.0006099934,0.007918469,0.00003566863,0.000005428416,6.765085e-7,0.000009687638,0.00000659743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1413886,"threshold_uncertainty_score":0.4716046,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400830732","doi":"10.5639/gabij.2022.1103.018","title":"Key factors for successful uptake of biosimilars: Europe and the US","year":2022,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Key (lock); Business; Medicine; Computer science; Computer security; Internal medicine","authors":[{"name":"Michael S Reilly","is_ca":false},{"name":"Philip J. Schneider","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03940386486012425,"gpt":0.2793923534529661,"spread":0.2399884885928418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001719309,0.0002638174,0.000532087,0.0001494555,0.001131632,0.00006317471,0.0003317276,0.0001361228,0.000307633],"category_scores_gemma":[0.0003926897,0.0001569374,0.0001986656,0.0003450503,0.000992359,0.00008307215,0.0003683352,0.0006205392,3.955348e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002529434,"about_ca_system_score_gemma":0.00009558869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.255647e-7,"about_ca_topic_score_gemma":0.000003198963,"domain_scores_codex":[0.9978946,0.000692778,0.000603505,0.0003018051,0.000114333,0.00039292],"domain_scores_gemma":[0.9983436,0.0006946336,0.0004662815,0.0001728126,0.0002562891,0.00006636287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006593082,0.001141275,0.04214954,0.0002518385,0.004598694,0.00006453277,0.008506111,0.00008030868,0.1957251,0.005779438,0.7037979,0.03131216],"study_design_scores_gemma":[0.009301324,0.002330992,0.02312597,0.00004682897,0.0007833984,0.0007511149,0.004915648,0.0002921747,0.05592681,0.005141772,0.896676,0.0007079309],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8418385,0.04983557,0.005709992,0.09134991,0.004153075,0.001676498,0.00311008,0.00006181141,0.002264581],"genre_scores_gemma":[0.9160567,0.0109203,0.005417849,0.06699067,0.0002201696,0.00006563307,0.00006456032,0.00007192002,0.0001921896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1928781,"threshold_uncertainty_score":0.8703716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3216742648","doi":"10.5639/gabij.2021.1003.016","title":"A critical review of substitution policy for biosimilars in Canada","year":2021,"lang":"en","type":"review","venue":"Generics and Biosimilars Initiative Journal","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Competition (biology); Business; Market competition; Public economics; Marketing; Medicine; Economics; Market economy","authors":[{"name":"Philip J. Schneider","is_ca":false},{"name":"Michael S Reilly","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2179399431878375,"gpt":0.3831076496905857,"spread":0.1651677065027482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00102951,0.0003920257,0.002600015,0.0004893036,0.0001143366,0.00007310812,0.0002957838,0.0002129566,0.0001325043],"category_scores_gemma":[0.001411471,0.0003906618,0.000507506,0.0006122927,0.0001308687,0.0001420823,0.0001133915,0.0005554768,0.000002499102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001058837,"about_ca_system_score_gemma":0.004143869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005993452,"about_ca_topic_score_gemma":0.005879942,"domain_scores_codex":[0.9967796,0.0001013856,0.002105738,0.0004367508,0.00006635862,0.00051013],"domain_scores_gemma":[0.9978085,0.0004015503,0.001123465,0.0002141466,0.0001765412,0.0002757694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000214041,0.0003142731,0.0003392735,0.159587,0.001007576,0.0001668471,0.00008663859,0.000008048853,8.681021e-7,0.06856056,0.497609,0.2722985],"study_design_scores_gemma":[0.0002721202,0.00004424835,0.00001540679,0.01963644,0.0001236388,0.0001272446,0.000009671651,0.00008699213,0.000003136426,0.003735863,0.9755476,0.0003976332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002275538,0.980559,0.0002693212,0.01375223,0.000577302,0.0004045768,0.00354556,0.000002424411,0.000887338],"genre_scores_gemma":[0.00001564632,0.9408448,0.0005960849,0.05800392,0.0003712407,0.00004911429,0.00007932971,0.00003749054,0.000002375645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4779386,"threshold_uncertainty_score":0.9998545,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401034735","doi":"10.5639/gabij.2023.1201.006","title":"Non-medical switching of biologicals/biosimilars: Canada, Europe and the US – a webinar report","year":2023,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Medicine; Internal medicine","authors":[{"name":"Michael S Reilly","is_ca":false},{"name":"Gail Attara","is_ca":false},{"name":"Ralph D McKibbin","is_ca":false},{"name":"Philip J. Schneider","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02511126627845165,"gpt":0.2745983956887593,"spread":0.2494871294103076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003192697,0.0002909346,0.0006534833,0.0001364488,0.000553308,0.00005252012,0.0003454967,0.0003432807,0.0001728881],"category_scores_gemma":[0.001387891,0.0001575797,0.0001308813,0.0006012461,0.0008632025,0.0000624979,0.0004104247,0.0008847802,0.000002878451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002858293,"about_ca_system_score_gemma":0.0005012656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001995801,"about_ca_topic_score_gemma":0.001489055,"domain_scores_codex":[0.9974793,0.0005893797,0.0008193578,0.0003753115,0.0002166826,0.0005199341],"domain_scores_gemma":[0.9981494,0.0007034913,0.0004862355,0.0002282755,0.0002831885,0.0001493866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007762004,0.0001757225,0.03367352,0.00009265411,0.00132589,0.002418861,0.0005259353,0.000007289879,0.06569889,0.0003124132,0.8814104,0.0135822],"study_design_scores_gemma":[0.01181457,0.001653023,0.202338,0.0006145937,0.0008128787,0.01840997,0.002277947,0.00194031,0.04461482,0.004145115,0.7097931,0.001585697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7361115,0.01384377,0.001837584,0.2409364,0.003037154,0.0006579792,0.0002266092,0.00008113575,0.003267964],"genre_scores_gemma":[0.8814834,0.02582713,0.001265367,0.09079572,0.0003402378,0.00001676761,0.00003325153,0.00004712573,0.0001909946],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1716174,"threshold_uncertainty_score":0.6425912,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3110075982","doi":"10.5639/gabij.2020.0903.022","title":"3rd Colombian educational workshop on regulatory assessment of biosimilars 2019 – Report","year":2020,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Pharmacovigilance; Workgroup; Medicine; Quality (philosophy); Health professionals; Political science; Medical education; Health care; Pharmacology; Adverse effect; Computer science; Law","authors":[{"name":"John-Joseph Borg","is_ca":false},{"name":"Yolanda Elias Gramajo","is_ca":false},{"name":"Andrea Laslop","is_ca":false},{"name":"Robin Thorpe","is_ca":false},{"name":"Wang Jian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05838303705914417,"gpt":0.3401759876671234,"spread":0.2817929506079792,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009029177,0.000318471,0.000575186,0.0001661672,0.0003287932,0.00005340594,0.0002797295,0.0003815862,0.0005442948],"category_scores_gemma":[0.0004307773,0.0002510724,0.0002268224,0.0003929283,0.0005374479,0.0001074338,0.0001457334,0.0008295132,0.000006126875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007127817,"about_ca_system_score_gemma":0.0004104282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":1.821589e-7,"about_ca_topic_score_gemma":0.000001612635,"domain_scores_codex":[0.997684,0.0004184462,0.0008258312,0.0004651626,0.0001977924,0.0004087541],"domain_scores_gemma":[0.9981544,0.0003863244,0.0006782062,0.0002462056,0.000341124,0.0001937096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002002508,0.0003804961,0.01252643,0.000035881,0.000599617,0.00008410366,0.0002261087,0.00001814265,0.07279716,0.0004654483,0.9084828,0.004183509],"study_design_scores_gemma":[0.005149689,0.00405465,0.3840235,0.0005363307,0.0008081343,0.002355365,0.001753614,0.0003849242,0.1264731,0.004381931,0.4682563,0.00182255],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1551398,0.01235835,0.006187297,0.799024,0.005639231,0.001110246,0.0009685517,0.0001051001,0.01946737],"genre_scores_gemma":[0.7535735,0.005378658,0.02435184,0.2150842,0.0008348809,0.0000198989,0.000170013,0.00008186448,0.0005051814],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.5984337,"threshold_uncertainty_score":0.9999942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401026462","doi":"10.5639/gabij.2023.1202.008","title":"Canadian prescribers’ attitudes and perceptions about ophthalmic biosimilars","year":2023,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Perception; Medicine; Psychology; Internal medicine; Neuroscience","authors":[{"name":"Michael S Reilly","is_ca":false},{"name":"Jane Barratt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.039198613817649,"gpt":0.3057897446700765,"spread":0.2665911308524275,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078753,0.0003252501,0.000394113,0.0005155073,0.001089057,0.0001808007,0.0002281003,0.0004167357,0.0007247805],"category_scores_gemma":[0.0001574445,0.0002589693,0.0001306465,0.0005421172,0.0005624729,0.0001721845,0.0001673399,0.0006909252,0.00005490141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009937698,"about_ca_system_score_gemma":0.0002240171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005402226,"about_ca_topic_score_gemma":0.001276671,"domain_scores_codex":[0.997969,0.0003150646,0.0004212852,0.0004262225,0.00009165423,0.0007767816],"domain_scores_gemma":[0.9990078,0.0001743098,0.0001404784,0.0001836567,0.0001799544,0.0003137857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.00006516959,0.00009612698,0.07973417,0.000057846,0.0006603296,0.0002321205,0.001140721,0.0000046867,0.07742,0.0001218021,0.829183,0.01128408],"study_design_scores_gemma":[0.002412415,0.0009734675,0.7326333,0.0002881951,0.0004280968,0.003589085,0.003261081,0.0002097637,0.009667594,0.003764775,0.241336,0.001436279],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.735314,0.02823924,0.0006872636,0.2152753,0.005193113,0.001095729,0.002252344,0.0003632313,0.01157979],"genre_scores_gemma":[0.8998575,0.03155513,0.003916426,0.06335044,0.0003409208,0.00002653143,0.0001085194,0.00007656997,0.0007679846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6528991,"threshold_uncertainty_score":0.9999862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047360337","doi":"10.5639/gabij.2020.0901.005","title":"It is time to change US trade policy to foster access to medicines","year":2020,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Negotiation; Biosimilar; Balance (ability); Business; Access to medicines; Sustainability; International trade; International economics; Economics; Economic growth; Political science; Medicine; Developing country; Law","authors":[{"name":"María Fabiana Jorge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2419709964383773,"gpt":0.3549841684586827,"spread":0.1130131720203054,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003265053,0.0002530052,0.0005093834,0.0004292454,0.0001805128,0.0003406403,0.0004388269,0.00009326837,0.001135755],"category_scores_gemma":[0.0001991658,0.0002513441,0.0001110765,0.000672654,0.00003598913,0.0003116992,0.0003367646,0.0002438649,0.0007482839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001064169,"about_ca_system_score_gemma":0.00005335956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":4.271149e-7,"about_ca_topic_score_gemma":0.000005164245,"domain_scores_codex":[0.9983526,0.00002250931,0.0006328759,0.0004219519,0.0000652899,0.000504781],"domain_scores_gemma":[0.9982475,0.00004151148,0.0002043995,0.0001384519,0.00004537789,0.00132274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000442651,0.00002432208,0.001719297,0.00001177719,0.00005832508,0.00001071092,0.003807587,0.0000190908,0.0001624245,0.00001711471,0.991272,0.002853089],"study_design_scores_gemma":[0.0004523714,0.0004033192,0.00601594,0.00002329949,0.00001129582,0.00001790129,0.00004803901,0.0009287058,0.0005891329,0.001191722,0.9899622,0.0003560249],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.003303692,0.0004938664,0.0007714231,0.9836418,0.0002366159,0.0003494383,0.0008442479,0.00001321348,0.01034568],"genre_scores_gemma":[0.0136911,0.001039339,0.0006587544,0.9823121,0.002221792,0.00002635169,0.000004581224,0.0000347048,0.00001130494],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01038741,"threshold_uncertainty_score":0.9999939,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4401026458","doi":"10.5639/gabij.2023.1202.007","title":"Extrapolation requires reading between the lines","year":2023,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Extrapolation; Reading (process); Computer science; Mathematics; Statistics; Philosophy; Linguistics","authors":[{"name":"Philip D Walson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05397317481298376,"gpt":0.3021157404149194,"spread":0.2481425656019356,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005227639,0.0001220851,0.0001162092,0.00007546425,0.0003950257,0.00006564613,0.0001312102,0.0001182705,0.00001122247],"category_scores_gemma":[0.0001237528,0.00007853533,0.00006897953,0.0001925857,0.000124469,0.000006475948,0.0001107427,0.0001532523,0.000003442931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007075254,"about_ca_system_score_gemma":0.00004427102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":2.441764e-7,"about_ca_topic_score_gemma":0.000004975016,"domain_scores_codex":[0.9991658,0.000115289,0.0002164095,0.000179726,0.00009339533,0.0002293687],"domain_scores_gemma":[0.9995201,0.00005319083,0.0001299452,0.0001229328,0.0001057058,0.00006817538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008215803,0.00002273134,0.09929734,0.00001447037,0.0002909794,0.00002958542,0.0005342789,0.00004756784,0.5122182,0.0000704082,0.3421789,0.04521336],"study_design_scores_gemma":[0.0008555482,0.000896005,0.2484576,0.00004189047,0.00009504991,0.0002606816,0.001133175,0.0005511495,0.06578098,0.002689026,0.6787094,0.0005294607],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742126,0.001477727,0.001949881,0.02105514,0.0003966422,0.0001100709,0.00005678034,0.00001938136,0.0007217015],"genre_scores_gemma":[0.9829309,0.006332623,0.0003113719,0.008498975,0.001758606,0.000005544502,0.0000887244,0.0000169367,0.00005629861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4464372,"threshold_uncertainty_score":0.3202578,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}